 Chemokine CXCL9
"Chemokine CXCL9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An INTEFERON-inducible CXC chemokine that is specific for the CXCR3 RECEPTOR.
| Descriptor ID |
D054370
|
| MeSH Number(s) |
D12.644.276.374.200.120.450 D12.776.467.374.200.120.450 D23.125.300.120.450 D23.469.200.120.450 D23.529.374.200.120.450
|
| Concept/Terms |
Chemokine CXCL9- Chemokine CXCL9
- CXCL9, Chemokine
- CXCL9 Chemokine
- Chemokine, CXCL9
- Monokine Induced by gamma Interferon Chemokine
- SCYB9 Chemokine
- Chemokine, SCYB9
- Small Inducible Cytokine B9
- Chemokine (C-X-C Motif) Ligand 9 Protein
- Mig Chemokine
- Chemokine, Mig
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL9".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL9".
This graph shows the total number of publications written about "Chemokine CXCL9" by people in UAMS Profiles by year, and whether "Chemokine CXCL9" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2025 | 1 | 0 | 1 | | 2023 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2011 | 0 | 1 | 1 | | 2009 | 1 | 1 | 2 | | 2008 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemokine CXCL9" by people in Profiles over the past ten years.
-
Sakai SA, Oyoshi H, Nakamura M, Taki T, Nomura K, Hojo H, Hirata H, Motegi A, Nakamura Y, Zenkoh J, Aokage K, Hamada A, Kojima M, Kuwata T, Tsuchihara K, Akimoto T, Soh J, Mitsudomi T, Tsuboi M, Ishii G, Suzuki Y, Suzuki A, Yamashita R, Kageyama SI. Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13?+?T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy. Br J Cancer. 2025 Oct; 133(6):795-808.
-
Al-Jaberi L, Simonds MM, Brescia AMC. CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment. Rheumatology (Oxford). 2023 07 05; 62(7):2594-2600.
-
Liu W, Liu Y, Fu Q, Zhou L, Chang Y, Xu L, Zhang W, Xu J. Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma. Oncotarget. 2016 Mar 22; 7(12):13976-83.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|